GW Pharmaceuticals $GWPH is a company I like for the long-term. However, we should anticipate some short to medium-term volatility. This is due to both general market risk as well as industry risk - cannabis related companies are all in the bearish correction part of its recent hype cycle. (Note: these risks are not independent, as general market risk aversion could spill over to the cannabis industry. ) GWPH Daily Chart(click to enlarge)From New high to Correction Mode:- After making a new all-time-high in September, price started to retreat in October. - This correction is still unwinding. In fact, the recent failure to climb back above $150 and the subsequent sharp downwards thrust suggests price will break below the rising trendline.- We are seeing GWPH south of the moving average cluster.- If price shows resistance around $140, we should have even more reason to believe in a significant bearish correction ahead.Bearish Target:- If price does break below the rising trendline and does stay below $140, we should look for GWPH to push towards the $97-$100 area, which represents the consolidation lows in 2017. - We should anticipate support here. A bullish market might even start buying around $110, which represents the middle of 2017 range.- Note that the 200-week SMA is around $110. GWPH Weekly Chart(click to enlarge)